article thumbnail

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

STAT

This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. The researchers found that, of the 55 physicians with ties to a pharmaceutical company, 91% accepted food and beverages, and 69% received compensation for travel and consulting, according to the analysis published in the BMJ.

article thumbnail

STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds

STAT

Oncologists were more likely to provide low-value cancer care after receiving money from pharmaceutical companies, and the findings raise questions about the extent to which industry influence may have led to patient harm, according to a new study. Continue to STAT+ to read the full story…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices

STAT

In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, giving it a monopoly until 2019. But like any pharmaceutical company with an eye toward the future, Celgene continued to seek other ways to wring profits from its development work.

FDA 116
article thumbnail

Gilead wins patent battle with US government over HIV PrEP drugs

Pharmaceutical Technology

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. In November 2019, the government sued Gilead over the company’s alleged patent infringement of the two PrEP drugs Descovy and Truvada. Gilead markets both Truvada and its successor Descovy.

article thumbnail

Collaborations between pharma and academia increase

European Pharmaceutical Review

Pharmaceutical companies who contributed to the survey include AbbVie, AstraZeneca, Boehringer Ingelheim and GSK. The survey also acknowledged more people are pursuing higher apprenticeship qualifications at Bachelor and Master degree level, which is double the number of level 6 and 7 apprenticeships done in 2019.

article thumbnail

Humira generic availability, cost, and dosage

The Checkup by Singlecare

The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. The pharmaceutical company that makes Hyrimoz is called Cordavis Limited. Cyltezo is citrate-free.

Dosage 97
article thumbnail

Pfizer to reach carbon net-zero by 2040

European Pharmaceutical Review

To achieve these goals, Pfizer aims to decrease its GHG emissions by 95 percent and its value chain emissions by 90 percent from 2019 levels by 2040. By doing so, Pfizer commits to reduce GHG emissions and to publicly report on its progress as well as develop climate resiliency plans, among other actions.